Search
for
Sort by
Research 361–390 of 788
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Central nervous system demyelination associated with tofacitinib use in alopecia areata: A case report and literature review
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Perspectives of Chinese Adult Patients with Alopecia Areata on Janus Kinase Inhibitors Therapy: A Qualitative Analysis Based on Social Media Platforms
- Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
- Regenerative Medicine-Based Treatment for Vitiligo: An Overview
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Myeloproliferative disorder associated with alopecia universalis
- Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
- Extracellular vesicles from IFN-γ-primed mesenchymal stem cells repress atopic dermatitis in mice
- Janus kinase inhibitors for alopecia areata
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Inflammatory loops in the epithelial–immune microenvironment of the skin and skin appendages in chronic inflammatory diseases
- Alopecia areata: a comprehensive review of clinical, immunologic, and genetic perspectives
- Research Progress in Chronic Autoimmune Urticaria
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo
- 151 High effectiveness of tildrakizumab over 52 weeks in patients with or without nail psoriasis: results from the phase IV POSITIVE Austrian subset
- Autoinmune Alopecia/Alopecia Areata
- mTOR signaling in hair follicle and hair diseases: recent progress
- Deciphering the Complex Immunopathogenesis of Alopecia Areata